Inventia Healthcare Limited has appointed seasoned technology executive Sanjay Nandavadekar as its new Head of IT, ushering in a leadership shift aimed at steering the company’s digital transformation journey in the pharmaceutical manufacturing sector.
Nandavadekar brings over two decades of experience deploying IT strategy across regulated industries. He previously served as Head of IT and Associate Vice President at Syngene International, where he led digital infrastructure and innovation initiatives for discovery services. His career also includes senior technology roles at Cipla and Sun Pharma.
“I look forward to leading impactful initiatives that align technology with business goals, enabling innovation, operational excellence, and compliance in this highly regulated environment,” Nandavadekar said. “I want to deliver solutions that create tangible value. I would like to play a key role in enhancing Inventia’s digital capabilities and supporting its growth journey”.
In his new role, Nandavadekar will oversee the full IT function at Inventia, a company known for developing and manufacturing complex generic and novel pharmaceutical products, ensuring that technology initiatives are tightly integrated with business objectives, regulatory compliance, and operational efficiency.
His arrival coincides with Inventia’s efforts to scale up its digital infrastructure and leverage technology to improve manufacturing processes, supply chain oversight, and quality assurance across its sites in Ambernath and Goregaon. Nandavadekar’s track record of deploying digital tools and cloud-based solutions is expected to contribute significantly to ongoing modernization efforts. Inventia Healthcare, founded in 1985 and based in Mumbai, has steadily grown its global footprint, operating in more than 50 countries. The company offers end-to-end pharma development and manufacturing services, servicing both emerging and regulated markets.
With this appointment, Inventia signals its commitment to strengthening its IT leadership and technological backbone. Under Nandavadekar’s guidance, the company aims to enhance digital workflows, bolster cybersecurity practices, and accelerate data-driven decision-making—critical factors for staying competitive in the high-stakes pharmaceutical manufacturing landscape.
